Kiran Thapaliya1, Sonya Marshall-Gradisnik1, Natalie Eaton-Fitch1, Markus Barth2, Maira Inderyas1, and Leighton Barnden1
1National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coast, Australia, 2The University of Queensland, Brisbane, Australia
Synopsis
Keywords: Infectious Disease, COVID-19, ME/CFS, hippocampus, infectious disease
Motivation: To study hippocampal atrophy in long COVID and Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS patients).
Goal(s): Our goal was to investigate hippocampal atrophy in long COVID and ME/CFS patients.
Approach: We used T1-weighted MP2RAGE data from 7T MRI and used FreeSurfer to estimate hippocampal subfield volumes in long COVID and ME/CFS patients.
Results: We found that hippocampal subfield volumes were larger in long COVID and ME/CFS patients compared to HC.
Impact: Our study showed atypical hippocampal atrophy in long COVID and ME/CFS
patients indicating that existing brain research findings in ME/CFS patients
may help better understand the neurological dysfunction in long COVID patients.
Introduction
Myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex illness that
affects multiple body systems and is characterised by a range of symptoms
including post-exertional malaise, neurocognitive impairment, or brain fog 1. Recently,
coronavirus 2019 (SARS-COV-2) has infected more than 760 million worldwide
causing Severe Acute Respiratory Syndrome Coronavirus 2 (SSARS-CoV-2) syndrome 2. It is estimated
that at least 10% of COVID-19 infected people (76 million) develop long COVID 3. Studies show
that 13-58% of long COVID patients met ME/CFS criteria 4 and exhibit symptoms of,
neurocognitive impairment or brain fog. One of the main causes of
neurocognitive impairment in long COVID and ME/CFS patients could be hippocampal
atrophy because the hippocampus and its subfields play an important role in
cognitive function and are also involved in memory function 5. Therefore,
the specific aim of this study was to investigate structural changes of
hippocampal subfields using ultra-high field 7T MRI in ME/CFS, long COVID, and
healthy controls.Methods and Materials
The
study was approved by the Griffith University Human Research Ethics Committee
(ID: 2022/666), all the methods were carried out with the relevant guidelines
and regulations following the Helsinki Declaration, and written
informed consent was obtained from all individuals. We recruited 30 ME/CFS
patients fulfilling the CCC and ICC criteria 6, 17 long COVID as defined by the
WHO clinical case definition 7, and 15 age-matched HC subjects.
MRI was performed
on a 7 T whole-body MRI research
scanner (Siemens Healthcare, Erlangen, Germany) with a 32-channel head coil
(Nova Medical Wilmington, USA). We acquired T1-weighted data using a
Magnetisation prepared 2 rapid acquisition gradient echo sequence (MP2RAGE).
MP2RAGE data were acquired sagittally using the following parameters:
repetition time (TR) = 4300 ms, echo time (TE) = 2.45 ms, inversion times:
first (TI1) = 840 ms, second TI2 = 2370 ms, flip angles (FA1) = 5o,
FA2 = 6o and spatial resolution = 0.75 mm3 with
matrix size = 256 × 300 × 320.
MP2RAGE images
were anatomically segmented using FreeSurfer version 7.4.18 (https://surfer.nmr.mgh.harvard.edu/) using the
default FreeSurfer command ‘recon-all’ on a Macintosh computer (Operating
system: Catalina, RAM=36GB, and core: 8).
Hippocampus
subfields were segmented using the FreeSurfer 7.4.1 hippocampus subfield
module. Using this module, the left and right hippocampal subfields: head,
body, and tail; parasubiculum, presubiculum, subiculum, coronis ammonis (CA1,
CA3, and CA4) head and body; granular cell layers of the dentate gyrus
(GC-ML-DG), molecular layer of the hippocampus (HP), fissure, fimbria, and
hippocampus-amygdala transition area (HATA) were defined. All hippocampal
subfields were visually checked for distortion-free segmentation. One ME/CFS subject and two long COVID
patients were excluded from the analysis due to inadequate segmentation.
Multivariate general
linear model (GLM) statistical analysis was performed to test for hippocampal
subfield volume differences of ME/CFS and long COVID patients, relative to HC
using SPSS version 29. After confirmation of homogeneity using Levene’s test,
the multivariate GLM was used to test for three group differences. Correction
for multiple comparisons was implemented using the Bonferroni method. Age, sex,
and total intracranial volume were included as nuisance covariates for group
comparisonsResults
ME/CFS vs HC
We found significantly
larger left subiculum head (p=0.002) and pre-subiculum head (p=0.005)
volumes in ME/CFS patients compared to healthy controls (see Figure 1).
Long COVID vs HC
Long COVID
patients also showed significantly larger left subiculum head (p=0.01)
and presubiculum head (p=0.004) volumes compared to HC (see Figure 1).
ME/CFS vs long COVID
We found no significant differences in the hippocampal subfield volumes between ME/CFS and
long COVID patients.Discussion
Increased hippocampal subfield volumes may reflect neurogenesis. An
increase in hippocampal neurogenesis could also be a response to the
environmental factors and stress 9 that trigger ME/CFS and long COVID symptoms. The estimation of hippocampal subfield volume could also be affected by the implementation of different
image processing pipelines. 10Conclusion
In summary, our analysis
shows changed hippocampal subfield volumes in ME/CFS and long COVID patients
with increments in the same hippocampal subfield volumes compared to HC. Therefore,
existing brain research findings in ME/CFS patients may help better understand the neurological dysfunction in long COVID patients. Future research
should study ME/CFS and long COVID patients together to get a better
understanding of the neurological link between both cohorts.Acknowledgements
We are thankful to Ms. Tania Manning
and Kay Schwarz for recruiting participants for this study. All radiographers
at the University of Queensland, and the patients and healthy controls who
donated their time and effort to participate in this study. References
1.Stussman,
B. et al. Characterization of Post–exertional Malaise in Patients With
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 11,
1025 (2020).
2.WHO Coronavirus (COVID-19) Dashboard.
https://covid19.who.int.
3.Centers for Disease Control and Prevention.
https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm
(2022).
4.Twomey, R. et al. Chronic Fatigue and Postexertional
Malaise in People Living With Long COVID: An Observational Study. Phys.
Ther. 102, pzac005 (2022).
5.Middlebrooks, E. H. et al. The hippocampus: detailed
assessment of normative two-dimensional measurements, signal intensity, and
subfield conspicuity on routine 3T T2-weighted sequences. Surg. Radiol.
Anat. 39, 1149–1159 (2017).
6. Carruthers, B. M. et al. Myalgic encephalomyelitis:
International Consensus Criteria. J. Intern. Med. 270, 327–338
(2011).
7. A clinical case definition of post COVID-19 condition by a
Delphi consensus, 6 October 2021.
https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
8.Fischl, B. FreeSurfer. NeuroImage 62, 774–781
(2012).
9.Toda, T., Parylak, S., Linker, S. B. & Gage, F. H. The
role of adult hippocampal neurogenesis in brain health and disease. Mol.
Psychiatry 24, 67–87 (2019).
10.Shaw, T. et al. Longitudinal
Automatic Segmentation of Hippocampal Subfields (LASHiS) using multi-contrast
MRI. NeuroImage 218, 116798 (2020).